Back to Search Start Over

Respiratory virus infections in decedents in a large, urban medical examiner's office.

Authors :
Brouwer AF
Wilson AM
Martin ET
Zelner J
Lephart PR
Jaworski A
Schmidt CJ
Source :
Public health [Public Health] 2023 Nov; Vol. 224, pp. 118-122. Date of Electronic Publication: 2023 Sep 25.
Publication Year :
2023

Abstract

Objective: Most respiratory virus surveillance relies on medically attended respiratory illness, but an understanding of the true patterns of infection independent of care-seeking behaviour would enhance clinical and public health responses to respiratory virus outbreaks. We evaluated the potential of decedent surveillance by estimating the burden of respiratory virus infection in decedents in a large, urban medical examiner's office.<br />Study Design: Observational.<br />Methods: In 2020-2022, we tested nasopharyngeal swabs from 4121 decedents in Detroit, Michigan for 15 respiratory viruses, including SARS-CoV-2, respiratory syncytial virus, and influenza virus A and B. We analysed infection prevalence over time and by age, sex, race/ethnicity, and manner of death.<br />Results: Of 4113 valid tests, 30.2% were positive for at least one virus, and 6.1% were positive for multiple viruses. All viruses were detected except for influenza A/H1N1 and influenza B. The most prevalent viruses were SARS-CoV-2 (15.7%), rhinovirus (11.2%), and adenovirus (4.9%), which were detected in all months. Most viruses exhibited decreasing prevalence with age, higher prevalence among Black and Hispanic than among White decedents and lower prevalence among deaths from natural causes; SARS-CoV-2 was a notable exception to the patterns by age and manner of death, instead reflecting community trends in catchment counties.<br />Conclusions: There was high prevalence and diversity of respiratory viruses in decedents entering a large, urban medical examiner's office. Decedent surveillance could offer a clearer picture of the true underlying burden of infection, motivating public health priorities for intervention and vaccine development, and augmenting data for real-time response to respiratory virus outbreaks.<br /> (Copyright © 2023 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1476-5616
Volume :
224
Database :
MEDLINE
Journal :
Public health
Publication Type :
Academic Journal
Accession number :
37757630
Full Text :
https://doi.org/10.1016/j.puhe.2023.08.029